Is Iodine Nasal Spray Safe? Potential Risks Explained

Povidone-iodine (PVP-I) nasal spray is generally safe for short-term use at dilute concentrations, typically 0.5% or lower, based on the clinical trial data available. The most common complaint is mild, temporary nasal irritation, which affected roughly a third of users in one Phase III trial but never caused anyone to stop treatment. That said, safety depends heavily on concentration, duration of use, and individual factors like thyroid health and pregnancy status, and those details matter more than the simple “yes, it’s safe” headline suggests.

Concentration Is the Single Biggest Safety Variable

Not all iodine nasal sprays are created equal, and the concentration of povidone-iodine in the solution shapes almost every safety outcome. Most products marketed for nasal use contain between 0.23% and 0.5% PVP-I, though some formulations go higher. Research on the relationship between PVP-I concentration and its germ-killing ability found that free iodine, the active component that does the actual work, peaks at around 0.1% concentration rather than climbing steadily with dose. A 10% solution, for instance, released far less free iodine than a 0.1% solution in laboratory testing.¹ This is a counterintuitive result that has practical implications: cranking up the concentration does not make the spray work better, but it does increase the likelihood of side effects.

A randomized trial testing PVP-I nasal spray against SARS-CoV-2 compared a 2.0% concentration to lower-concentration groups and saline. The higher-concentration group reported considerably more nasal burning, while saline and low-concentration PVP-I sprays were well tolerated.² The takeaway is straightforward: dilute formulations sit in a sweet spot where they retain antimicrobial activity without provoking much discomfort.

Nasal Irritation and How Common It Really Is

The side effect you are most likely to experience is nasal irritation, sometimes described clinically as “rhinalgia.” In a Phase III trial of a 0.5% PVP-I nasal spray (Nasodine) used for the common cold, about 37% of people in the treatment group reported nasal irritation at least once over 20 scheduled doses, compared to around 7% in the placebo group. That sounds like a big gap, but context helps: the irritation was rated mild in roughly 83% of those cases, was always transient, and no one dropped out of the study because of it.³ A brief sting or mild burning after spraying seems to be the typical experience, and it fades quickly.

Lab studies add some reassurance at the cellular level. When a PVP-I nasal formulation was applied to cultured human nasal epithelial cells, researchers found no toxicity, no damage to the barrier function of the cell layer, and no slowing of the tiny hair-like cilia that sweep mucus through the nose.⁴ That ciliary function finding matters because impaired mucociliary clearance would leave your nasal passages less able to trap and remove pathogens on their own. At the concentrations tested, the spray did not interfere with that built-in defense.

Does the Iodine Get Into Your Bloodstream?

Yes, some iodine does get absorbed, and this is the concern that drives most of the more serious safety questions. A Phase 1 study specifically designed to measure iodine absorption from a 0.5% PVP-I nasal spray found that serum iodine levels rose after each dose. After a single first dose, the average peak concentration went from a baseline of about 65 micrograms per liter up to 90. By the 42nd dose on the third day, the peak climbed to about 242 micrograms per liter.⁵ The researchers judged these increases to be within the range a healthy thyroid can handle without disruption, essentially the gland’s built-in capacity to regulate itself when extra iodine arrives.

That “within adaptive capacity” conclusion applies to people with normal thyroid function. It does not automatically extend to everyone, and this is where the safety picture gets more nuanced.

Thyroid Risks With Longer or Repeated Use

The thyroid gland uses iodine to build its hormones, and it has a self-protective mechanism that dials down iodine uptake when levels get too high. In most people, this escape mechanism works well and prevents problems. But in people whose thyroid is already compromised, whether by autoimmune disease, prior surgery, radiation, or other injury, the escape mechanism can fail, and excess iodine can push the gland into either underactivity or overactivity.⁶

The most direct evidence on this comes from a study of patients treated with PVP-I over a long period. Among 27 long-term PVP-I users, inorganic iodine levels in the blood were significantly elevated compared to controls. Three of those 27 developed subclinical hypothyroidism, one developed mild hyperthyroidism, and seven more were suspected of subclinical hyperthyroidism. The authors concluded that anyone on PVP-I for an extended time should be monitored for thyroid dysfunction.⁷ That study was not specific to nasal spray (it included topical wound applications, which involve greater surface area and potentially more absorption), but the principle holds: the longer you use PVP-I in any form, the more likely you are to accumulate enough iodine to stress the thyroid.

For the typical scenario of using an iodine nasal spray for a few days during a cold, the absorbed iodine load is modest and unlikely to cause thyroid trouble in someone with a healthy gland. The risk increases if you have Hashimoto’s thyroiditis, Graves’ disease, a history of thyroid nodules, or any condition where your thyroid is already on shaky ground. If that describes you, it is worth talking to your doctor before picking up an iodine-based nasal spray.

What Happens to Your Nose’s Microbial Community

Your nasal passages are home to a diverse microbial ecosystem, and PVP-I is an antiseptic that does not discriminate between pathogens and commensal bacteria. Studies have consistently shown that it delivers a sharp, dramatic reduction in the total bacterial load inside the nose. One trial measured a reduction of roughly 3.5 log units (meaning it wiped out more than 99.9% of detectable bacteria) within five minutes of application. The species hit hardest included Staphylococcus, Corynebacterium, and Cutibacterium acnes. No adverse effects or increases in mucociliary clearance time were reported among subjects.⁸

By 24 hours after application, the bacterial load had largely recovered, with the reduction dropping to around 1 log unit.⁹ A separate study looking at surgery patients who received intranasal PVP-I actually found that bacterial diversity increased after application, measured by several standard ecological indices, even as the relative abundance of Staphylococcus trended downward.¹⁰ That increase in diversity likely reflects PVP-I knocking back dominant species like Staphylococcus and giving rarer organisms room to grow back in their absence.

The evidence suggests the nasal microbiome bounces back relatively quickly from short-term PVP-I exposure. Whether repeated daily use over weeks or months could reshape it in lasting ways is something the current research does not definitively answer. For occasional or short-course use, the disruption appears to be transient.

Does It Damage Your Sense of Smell?

Loss of smell was a particular concern during the COVID-19 pandemic, both because the virus itself could damage olfactory function and because people were spraying various antiseptics into their noses at home. The randomized trial that compared PVP-I nasal spray to saline in COVID-19 patients used a standardized smell identification test and found that olfactory scores improved by at least one category across all groups, including the PVP-I group.² That is not definitive proof that PVP-I is harmless to the olfactory nerve, given that the improvement could reflect recovering from the virus rather than the spray itself, but it is reassuring that the spray group did not fare worse. Similarly, low-concentration PVP-I liposomal spray applied to the nasal mucosa of healthy volunteers did not cause detectable damage to the multi-layered ciliated lining of the nose or impair nasal function.¹¹

There have been occasional anecdotal reports of temporary smell changes from people using higher concentrations or homemade iodine rinses, but these are not well documented in the peer-reviewed literature. The controlled studies available at standard commercial concentrations have not flagged olfactory damage as a risk.

Pregnancy, Children, and Other Vulnerable Groups

Pregnancy is the population where caution matters most. Iodine crosses mucosal membranes and enters the bloodstream, as described above, and from there it can reach the developing fetus. The fetal thyroid begins concentrating iodine during the first trimester, and excess iodine exposure during that window could theoretically disrupt fetal thyroid development. A review in BJOG raised this concern specifically, noting that PVP-I absorbed through skin or mucous membranes causes a spike in urinary iodine excretion and short-term changes in maternal thyroid hormone levels, effects that could have consequences for the embryo during critical developmental stages.¹² The prudent approach for pregnant people is to avoid iodine nasal sprays unless specifically directed otherwise by a healthcare provider.

For children, the evidence is thinner but not necessarily alarming. A review of PVP-I use in sinonasal and oral cavities during the COVID-19 era noted that adverse events with oral PVP-I use had not been reported in conscious adults or children.¹³ The main concern in pediatric populations is the same thyroid-sensitivity issue seen in adults, amplified by the fact that younger children have smaller thyroid glands and may be more susceptible to iodine-induced dysfunction. Most product labels and clinical guidelines do not recommend routine use of PVP-I nasal spray in young children without medical supervision.

People with known iodine allergy are an obvious group to steer clear. True anaphylactic allergy to iodine itself is rare, and what is often called “iodine allergy” frequently involves reactions to specific iodine-containing compounds like contrast dyes rather than elemental iodine. Still, if you have had a documented allergic reaction to povidone-iodine specifically, a nasal formulation is off the table.

Does It Actually Work Well Enough to Justify Using It?

Safety is only half the question most people are really asking. The efficacy picture is more mixed than the marketing around these products sometimes implies, and understanding the evidence helps you weigh whether the mild risks are worth it.

For the common cold, the Phase III Nasodine trial found that the spray offered a modest benefit over saline in the overall study population, reducing global symptom severity by about 13%, a difference that narrowly missed statistical significance. The benefits grew larger in subgroups: people who started treatment within 24 hours of their first symptoms saw about a 40% reduction in global symptom severity compared to saline, and those with confirmed viral infections saw about a 23% benefit.³ Those subgroup results are interesting but need to be interpreted with caution, since post-hoc analyses of subgroups always look more impressive than the overall finding.

For COVID-19, results have been similarly qualified. A small pilot trial found that 0.23% PVP-I nasal rinses reduced the average period of viral detectability to about 10 days, compared to about 12-13 days for saline and no-treatment groups.¹⁴ But the other randomized trial that directly measured nasopharyngeal viral load found that PVP-I did not demonstrate virucidal activity in COVID-19 positive outpatients, despite the spray being well tolerated at lower concentrations.² The disconnect between PVP-I’s impressive lab performance against viruses and its underwhelming results in living patients is one of the more frustrating themes in this literature. Killing a virus on a lab bench in 15 seconds is not the same as eliminating it from the complex, mucus-lined environment of a real human nose.

Drug Interactions and Other Practical Warnings

Povidone-iodine can interact with certain medications. The most well-known interaction is with lithium, a drug used for bipolar disorder. Excess iodine can compound lithium’s tendency to suppress thyroid function, raising the risk of hypothyroidism in people taking both. If you are on lithium, an iodine nasal spray used more than very occasionally could push you into trouble.

People taking other thyroid-affecting medications, including amiodarone (a heart rhythm drug that contains substantial iodine itself), should also be cautious. Stacking additional iodine from a nasal spray on top of a drug that already loads the body with iodine can overwhelm the thyroid’s adaptive capacity.

There is also a practical consideration with timing if you use other nasal sprays. Iodine is an oxidizer, and applying it simultaneously with certain nasal corticosteroids or saline solutions could theoretically reduce the effectiveness of either product. Using them at least 15 to 30 minutes apart is a sensible precaution, though formal interaction studies between PVP-I nasal spray and common nasal medications are scarce.

Homemade Preparations and the Dilution Problem

During the pandemic, interest in iodine nasal sprays outpaced the availability of commercial products, and many people turned to do-it-yourself formulations made by diluting drugstore Betadine or generic PVP-I solutions. This introduces a layer of risk that the clinical trial data does not capture. Standard off-the-shelf PVP-I antiseptic is typically sold at 10% concentration, which needs to be diluted by a factor of 20 or more to reach the 0.5% or lower concentrations tested in trials. Getting that dilution wrong is easy, and the consequences are not symmetrical: too strong, and you get significant nasal burning plus increased iodine absorption; too weak, and the spray is probably ineffective.

The lab data on free iodine concentration helps explain why “more is more” does not apply here. At 10% concentration, the PVP-I molecule holds onto iodine more tightly, releasing far less of the free iodine that actually kills microbes than a properly diluted 0.1% solution does.¹ So using undiluted or barely diluted Betadine in your nose is both harsher on the tissue and less effective as an antimicrobial. If you are going to use a PVP-I nasal spray, a commercially formulated product with a verified concentration is a much safer bet than a kitchen chemistry experiment.

Beyond concentration accuracy, commercial nasal spray formulations are typically buffered and pH-adjusted to be gentler on the mucosa. Homemade dilutions using tap water or unbuffered saline may differ in osmolality and pH, adding another variable that could increase irritation or reduce stability. The people in clinical trials were not using makeshift preparations, and the safety data from those trials cannot be directly transferred to homemade versions.